Dean of the College of Public Health at the University of Oklahoma Health Sciences Center, and Chairman of the ISTH
World Thrombosis Day Steering Committee.
The impact of sub-optimal management strategies on outcomes demonstrated in the GARFIELD-AF presentations at ISTH
suggests a cause for ongoing concern.
The primary safety outcome is modified ISTH
Part of this work was presented at the XXIII ISTH
Congress, Kyoto (Japan), July 25, 2011.
With our experience spearheading the ISTH
harmonization effort that contributed a payment kernel to the ISO 20022 standard, as well as possessing the infrastructure that facilitated that work, the IFX Forum stands ready and willing to lead a new collaboration with other attendees, including NACHA, OAGI, SWIFT and X9.
About the ISTH
Founded in 1969, the ISTH
is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders.
scoring system looks first to answer the question of whether the index patient has an underlying disorder known to be associated with DIC.
Nonclinical findings were also presented at the ISTH
Congress, showing that OBI-1 corrected biomarkers of blood coagulation in vitro in a dose-dependent, anti-OBI-1 inhibitor titer-dependent fashion, including in plasma taken from individuals with congenital hemophilia A who have inhibitors.
van den Besselaar AMHP, Barrowcliffe TW, Houbouyan-Reveillard LL, Jespersen J, Johnston M, Poller L, Tripodi A, on behalf of the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the ISTH
The primary efficacy endpoint is stroke and systemic events, while the primary safety endpoint is the occurrence of major and clinically relevant non-major bleeding events, using the sensitive ISTH
(International Society on Thrombosis and Haemostasis) scale.
In addition, ELIQUIS met the key secondary endpoints of superiority on efficacy and on ISTH
(International Society on Thrombosis and Haemostasis) major bleeding compared to warfarin.
On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH